These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16236384)

  • 21. Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention.
    Hendrickx H; McEwen BS; Ouderaa Fv
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():1-5. PubMed ID: 16290269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of age and glucoregulation on cognitive performance.
    Messier C; Tsiakas M; Gagnon M; Desrochers A
    J Clin Exp Neuropsychol; 2010 Oct; 32(8):809-21. PubMed ID: 20209424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.
    Abbatecola AM; Rizzo MR; Barbieri M; Grella R; Arciello A; Laieta MT; Acampora R; Passariello N; Cacciapuoti F; Paolisso G
    Neurology; 2006 Jul; 67(2):235-40. PubMed ID: 16864814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
    Zeymer U
    Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs.
    Studzinski CM; Araujo JA; Milgram NW
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):489-98. PubMed ID: 15795058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular factors in dementia].
    Bidzan L
    Psychiatr Pol; 2005; 39(5):977-86. PubMed ID: 16358596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes.
    Alvarez EO; Beauquis J; Revsin Y; Banzan AM; Roig P; De Nicola AF; Saravia F
    Behav Brain Res; 2009 Mar; 198(1):224-30. PubMed ID: 19041902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes.
    Brands AM; Kessels RP; Hoogma RP; Henselmans JM; van der Beek Boter JW; Kappelle LJ; de Haan EH; Biessels GJ
    Diabetes; 2006 Jun; 55(6):1800-6. PubMed ID: 16731845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications.
    Lobnig BM; Krömeke O; Optenhostert-Porst C; Wolf OT
    Diabet Med; 2006 Jan; 23(1):32-9. PubMed ID: 16409563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognizing the rising impact of diabetes in seniors and implications for its management.
    Drab SR
    Consult Pharm; 2009 Jun; 24 Suppl B():5-10. PubMed ID: 19555130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human aging and dementia.
    Studzinski CM; Christie LA; Araujo JA; Burnham WM; Head E; Cotman CW; Milgram NW
    Neurobiol Learn Mem; 2006 Sep; 86(2):197-204. PubMed ID: 16616528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cognitive reserve and neural networks in normal aging and Alzheimer's disease].
    Kalpouzos G; Eustache F; Desgranges B
    Psychol Neuropsychiatr Vieil; 2008 Jun; 6(2):97-105. PubMed ID: 18556268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
    Watson GS; Craft S
    J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of diabetes mellitus in old age in Japan.
    Nakano T; Ito H
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S76-81. PubMed ID: 17644210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum uric acid and cognitive function in community-dwelling older adults.
    Schretlen DJ; Inscore AB; Jinnah HA; Rao V; Gordon B; Pearlson GD
    Neuropsychology; 2007 Jan; 21(1):136-40. PubMed ID: 17201536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes.
    Morrison JF; Shehab S; Sheen R; Dhanasekaran S; Shaffiullah M; Mensah-Brown E
    Exp Physiol; 2008 Feb; 93(2):213-22. PubMed ID: 17911358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic effects of type 2 diabetes mellitus on cardiac muscle contraction in the Goto-Kakizaki rat.
    Howarth FC; Shafiullah M; Qureshi MA
    Exp Physiol; 2007 Nov; 92(6):1029-36. PubMed ID: 17675413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered glycemia and brain-update and potential relevance to the aging brain.
    McCall AL
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():70-5. PubMed ID: 16198444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related cognitive decline in patients with mood disorders.
    Gualtieri CT; Johnson LG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):962-7. PubMed ID: 18243461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.